Brigham Young University

BYU ScholarsArchive
FHSS Mentored Research Conference

Family, Home, and Social Sciences

2016-04-07

Novel Pharmacological Target: Characterization of a3b2 nAChRs
expressed in Xenopus Laevis Oocytes
Doris Jackson
Brigham Young University - Provo, dorisgclark@gmail.com

Marcel Hall
Brigham Young University - Provo

J. Kolb
B. Todd Jr.
Follow this and additional works at: https://scholarsarchive.byu.edu/fhssconference_studentpub

D. Pugh

Part of the Neuroscience and Neurobiology Commons

See next page for additional authors

The Annual Mary Lou Fulton Mentored Research Conference showcases some of the best
student research from the College of Family, Home, and Social Sciences. The mentored learning
program encourages undergraduate students to participate in hands-on and practical research
under the direction of a faculty member. Students create these posters as an aide in presenting
the results of their research to the public, faculty, and their peers.

BYU ScholarsArchive Citation
Jackson, Doris; Hall, Marcel; Kolb, J.; Todd, B. Jr.; Pugh, D.; Vance, B.; Klienstuber, B.; Drecketts, R.; and
Sudweeks, S. N., "Novel Pharmacological Target: Characterization of a3b2 nAChRs expressed in Xenopus
Laevis Oocytes" (2016). FHSS Mentored Research Conference. 295.
https://scholarsarchive.byu.edu/fhssconference_studentpub/295

This Poster is brought to you for free and open access by the Family, Home, and Social Sciences at BYU
ScholarsArchive. It has been accepted for inclusion in FHSS Mentored Research Conference by an authorized
administrator of BYU ScholarsArchive. For more information, please contact scholarsarchive@byu.edu,
ellen_amatangelo@byu.edu.

Authors
Doris Jackson, Marcel Hall, J. Kolb, B. Todd Jr., D. Pugh, B. Vance, B. Klienstuber, R. Drecketts, and S. N.
Sudweeks

This poster is available at BYU ScholarsArchive: https://scholarsarchive.byu.edu/fhssconference_studentpub/295

Novel Pharmacological Target: Characterization of a3b2
nAChRs expressed in Xenopus Laevis Oocytes
D. Jackson, M. Hall, J. Kolb, B. Todd Jr., D. Pugh, B. Vance, B. Klienstuber, R. Drecketts, S. N. Sudweeks

The Center for Neuroscience, Department of Physiology & Developmental Biology
Brigham Young University, Provo, UT.

We have identified two subtypes of the novel
a3b2 nicotinic acetylcholine receptor (nAChR)
found
within
interneurons
of
the
hippocampus. This novel receptor may be a
valuable pharmacological target in drug
development for disease such as Alzheimer’s
disease (AD) which is largely characterized by
degeneration of the hippocampus.
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Fig. 1: Representation of two-electrode whole
cell voltage clamp. We used a pressurized
perfusion system that quickly changes the
solution applied to the oocyte.
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Recordings were obtained through two-electrode
voltage clamp (Figure 1). Traces were recorded
using Clampex 9.2 software (Axon Instruments,
Sunnyvale CA) and analyzed on ClampFit 9.2 (Axon
Instruments, Sunnyvale CA). Acetylcholine was
suspended in OR-2 solution and was perfused over
the oocyte for 3 seconds every 2 minutes.
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Fig. 2: Q-PCR of individual interneurons of the
Stratum Oriens and Stratum Radiatum showed
94% of neurons had a detectable expression
of nAChR subunits.
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Fig. 4: Traces of possible stoichiometries of
nAChRs expressed in Xenopus laevis oocytes.
A) a3β2 6:1 nAChR with 3 second 10mM of ACh.
B) a3β2 1:6 nAChR with 3 second 333 mM of ACh.
C) a3 control with 3 second 333 mM of ACh.
D) β2 control with 3 second 10 mM of ACh.
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Fig 3: Results from Q-PCR of interneurons.
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We mixed ratios of a3:b2 1:6 and a3:b2 6:1 to
increase the likelihood of expression of each
probable stoichiometry. Each oocyte was injected
with 50.6 nL of mRNA for a total of 75.9 ng of mRNA
per oocyte. The oocytes were stored a solution of
OR-2 Ca2+ at 14-17˚C until recordings were
obtained 7-9 days later.

Fig. 6: Dose-Response curves. a3β2 6:1
nAChR vs. a3β2 1:6 nAChR shows significant
difference between the EC50s. 1:6 EC50=11 μM
6:1 EC50=184 M **p<0.001.
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METHODS
Plasmids containing human a3 and β2 nAChR
genes were linearized by restriction digest with SacI
(New England BioLabs). The mRNA was then
transcribed, capped on the 5’ end, a poly(A) tail was
added, and LiCL purification was performed using
the mMessage mMachine® T7 Ultra Kit (Ambion ,
Carlsbad CA) according to the protocol provided.
RNA was re-suspended in TE Buffer (Bioexpress,
Layton UT) and stored at -20˚C.
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Fig 5: IV Plot
for a3β2 6:1
nAChR (Red).
IV Plot of a3β2
1:6 (Blue). The
reversal
potential for
both is ~-15
mV.

Fig. 7: Hippocampal degeneration is
characteristic of AD. The locality of a3β2 coexpression makes it a possible target for
cognitive drug therapies.

CONCLUSIONS
 a3β2 containing receptors are found in rat
hippocampal interneurons
 Two likely functional subunit stoichiometries for
a3β2 nAChRs
 a3β2 nAChRs may be a potential
pharmacological target for cognitive
enhancement therapy due to their location in the
hippocampus and role in learning and memory

